Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

906 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal is to conduct a 5-year prospective, randomized controlled trial to test an innovative, community-based intervention using posterior and anterior fundus photography of the optic nerve and macula and intraocular eye pressure measurements to improve access and utilization of eye care to detect, treat, and manage high-risk patients with previously undiagnosed glaucoma and other eye diseases. Research shows that subject failure to attend follow-up eye care appointments diminishes any previous benefits of community screenings for glaucoma. Greater adherence to follow-up visits can reduce glaucomatous blindness.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility of Teleglaucoma Versus Conventional Clinical Evaluation for Diagnostic Accuracy and Management Recommendations in Patients With Glaucoma

NCT03587454

Teleglaucoma Teleophthalmology Glaucoma

COMPLETED NA

Glaucoma Screening to Enhance At-Risk Californians' Health

NCT06854198

Glaucoma

NOT_YET_RECRUITING NA

Community Glaucoma Screening Follow-up

NCT00956865

Glaucoma

COMPLETED NA

Evaluating Home Testing Devices for the Management of Glaucoma

NCT05325996

Glaucoma, Open-Angle

COMPLETED NA

Interest in Electronic Applications for Patients With Glaucoma

NCT02659709

Glaucoma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The project will be divided into following parts:

* Phase 1 will consist of recruiting patients from primary care offices and federally qualified health centers across Philadelphia and Chester counties. Using fundus photography of optic nerve and macula via telemedicine and measurement of intraocular pressure, eye disease will be detected at Visit 1, followed by a comprehensive eye exam by a glaucoma specialist in the primary care setting to confirm the diagnosis (Visit 2) of qualifying participants requiring further evaluation. Predictive accuracy of optic nerve images to detect glaucoma, glaucoma suspect and other eye diseases as confirmed by the comprehensive eye exam will be evaluated.
* Phase 2 will involve consenting, enrolling, and randomizing the qualifying participants confirmed by diagnosis at Visit 2 to either the Usual Care group or the Enhanced Intervention group and scheduling follow-up eye exams with a local, general ophthalmologist in an office-based setting (Visit 3). Enhanced intervention will use patient navigators and a social worker to reduce barriers to follow-up eye care.
* Phase 3 will involve monitoring the randomized participants attendance of proximal (1-2 months) and distal (3 years) follow-up care appointments (Visits 3-8) with a local ophthalmologist. Adherence to recommendations for follow-up eye care will be the primary outcome measure. A comprehensive estimation of intervention costs and cost-effectiveness of detecting eye diseases and vision impairment in a high-risk population will also be conducted. Protocols, materials, and results will be disseminated to other organizations, stakeholders and communities in order to expand detection of glaucoma, other eye diseases, and visual impairment, and to further refine these approaches.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Glaucoma Suspect Diabetic Retinopathy Ocular Hypertension Cataract Branch Retinal Vein Occlusion Branch Retinal Arterial Occlusion Central Retinal Vein Occlusion Central Retinal Artery Occlusion Epi-retinal Membrane Macular Degeneration Drusen Loss of Vision

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Phase 1: Telemedicine Screening Participants

Participants across the Philadelphia, PA region were invited to participate in free eye screenings at primary care physician offices or health centers. Screenings included images of optic nerve and macula using non-contact, autofocus, hand-held fundus cameras (Volk Optical, Mentor, Ohio, USA) and measuring Intraocular Pressure (IOP) in millimeters of mercury (mm Hg) with non-contact rebound tonometers TA01I (ICare, Helsinki, Finland).

Group Type EXPERIMENTAL

Free Eye Screenings

Intervention Type OTHER

This group will receive free eye screening and follow-up comprehensive ophthalmic exam if recommended.

Phases 2 and 3: Enhanced Intervention Group

From eye screening results (visit 1), Phase 2 includes participants requiring further evaluation received comprehensive eye exam to confirm diagnosis (visit 2). Following confirmation diagnosis, patients were randomized to the Enhanced Intervention Group and were referred to a general ophthalmologist for follow-up eye care. Patient navigation and a social worker and referred to a general ophthalmologist close to the current health center or primary care physician office where they received the non dilated eye exam. Prior to all follow-up visits, patients in the Enhanced Intervention Group were provided a scheduled appointment and received a personal phone call reminding them to attend. Patients received necessary interpretation services and educational materials.

Phase 3. Includes following this group over a 5 year period for adherence to eye care.

Group Type EXPERIMENTAL

Enhanced Intervention

Intervention Type OTHER

This group will receive ophthalmic referral and a navigator for assistance in scheduling appointments; confirming appointments via phone, mail, email and/or text message; arranging transportation through Customized Community Transportation (CCT) and Philadelphia Paratransit Service; and trained medical interpreters as needed.

Phases 2 and 3: Usual Care Group

From eye screening results (visit 1), Phase 2 includes participants requiring further evaluation received comprehensive eye exam to confirm diagnosis (visit 2). Following confirmation diagnosis, patients were randomized to the Usual Care Group and were referred to a general ophthalmologist for follow-up eye care. These patients were scheduled for their initial follow-up visit based on the recommendations of our study physicians so the research team was able to track outcomes. This group represents a realistic choice currently available for patients. Practice patterns vary depending on the resources, staff time, and services available within each local ophthalmology practice.

Phase 3. Includes following this group over a 5 year period for adherence to eye care.

Group Type EXPERIMENTAL

Usual Care

Intervention Type OTHER

This group will receive ophthalmic referral.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Free Eye Screenings

This group will receive free eye screening and follow-up comprehensive ophthalmic exam if recommended.

Intervention Type OTHER

Enhanced Intervention

This group will receive ophthalmic referral and a navigator for assistance in scheduling appointments; confirming appointments via phone, mail, email and/or text message; arranging transportation through Customized Community Transportation (CCT) and Philadelphia Paratransit Service; and trained medical interpreters as needed.

Intervention Type OTHER

Usual Care

This group will receive ophthalmic referral.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* African-American, Hispanic, or Asian individuals over age 40
* Caucasian individuals over age 65
* Individuals of any ethnicity, over age 40 with a family history of glaucoma
* Individuals of any ethnicity, over age 40 with diabetes
* Individuals who meet one of the above criteria who have not seen an ophthalmologist in the past year